Possibilities of aggressive oncosurgery in the treatment of IIA – IIIB stages of cervical cancer-Reference-Cited by-同舟云学术

Possibilities of aggressive oncosurgery in the treatment of IIA – IIIB stages of cervical cancer

Published:2022-11-22 Issue:24 Volume: Page:54-59
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Khakimov G. A.¹^ORCID,Tashmetov M. N.²,Khakimova G. G.¹^ORCID,Musurmonov Kh. U.¹^ORCID,Khakimova Sh. G.³^ORCID

Affiliation:

1. Tashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology; Tashkent Pediatric Medical Institute

2. Tashkent city branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology

3. Tashkent Pediatric Medical Institute; P. A. Herzen Moscow Cancer Research Institute – branch of the National Medical Research Center for Radiologyow

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference11 articles.

1. Moshkovich O., Lebrun-Harris L., Makaroff L. et al. Challenges and Opportunities to Improve Cervical Cancer Screening Rates in US Health Centers through Patient-Centered Medical Home Transformation. Adv. Prev. Med. 2015; 2015: 182073. doi: 10.1155/2015/182073

2. Ferlay J., Colombet M., Soerjomataram I. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer. 2019 Apr 15; 144(8):1941–1953. doi: 10.1002/ijc.31937

3. Kaprin A. D., Starinsky V. V., Petrova G. V. Malignant neoplasms in Russia in 2017 (morbidity and mortality). M., 2018. 250 p.

4. Ryeyes Santiago D. K., Khadzhimba A. S., Sobolev I. V. et al. Results of combined treatment of cervical canceruterus stages IIA–IIIB. Tumors of the female reproductive system 2018;14(4):50–5.

5. Gong Lin M. D., Zhang Jia-Wen M.D., Yin Ru-Tie M.D. et al. Safety and efficacy of neoadjuvant chemotherapy followed by radical surgery versus radical surgery alone in locally advanced cervical cancer patient. Int. J. Gynecol Cancer 2016;26(4):722–8. PMID: 26905330. DOI: 10.1097/IGC.0000000000000658.